BVC.Lライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (2 5月 2024 @ 23:55):

BATM Advanced Communications Ltd., together with its subsidiaries, provides real-time technologies for networking solutions and bio-medical systems in Israel, the United States, and Europe...

Stats
本日の出来高	290 273
平均出来高	391 616
時価総額	83.24M
EPS	£0 ( 2024-03-13 )
Last Dividend	£0.740 ( 2021-12-09 )
Next Dividend	£0 ( N/A )
P/E	0
ATR14	£0.292 (1.55%)

Batm Advanced 相関

10 最も正の相関
WINE.L	0.873
DPEU.L	0.872
RMMC.L	0.833
CNIC.L	0.826
WTE.L	0.803

10 最も負の相関
CMET.L	-0.86
CAMB.L	-0.849

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Batm Advanced 財務諸表

Annual	2023
収益:	£122.83M
総利益:	£39.89M (32.48 %)
EPS:	£-0.000400

FY	2023
収益:	£122.83M
総利益:	£39.89M (32.48 %)
EPS:	£-0.000400

FY	2022
収益:	£116.12M
総利益:	£37.96M (32.69 %)
EPS:	£0.00350

FY	2021
収益:	£140.04M
総利益:	£51.06M (36.46 %)
EPS:	£0.0326

Financial Reports:

No articles found.

Batm Advanced Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Batm Advanced Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 7.50 - good (75.01%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	£0.0500	2000-05-08
Last Dividend	£0.740	2021-12-09
Next Dividend	£0	N/A
Payout Date	2022-01-05
Next Payout Date	N/A
# dividends	6	--
Total Paid Out	£3.33	--
Avg. Dividend % Per Year	0.11%	--
Score	1.38	--
Div. Sustainability Score	7.50
Div.Growth Potential Score	0
Div. Directional Score	3.59	--

Next Divdend (Est)
(2025-07-18)

£0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

1.38

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2000	£0.0500	0.01%
2001	£0	0.00%
2002	£0	0.00%
2003	£0	0.00%
2004	£0	0.00%
2005	£0	0.00%
2006	£0	0.00%
2007	£0	0.00%
2008	£0.500	1.61%
2009	£0.690	2.06%
2010	£0.550	1.06%
2011	£0.800	3.60%
2012	£0	0.00%
2013	£0	0.00%
2014	£0	0.00%
2015	£0	0.00%
2016	£0	0.00%
2017	£0	0.00%
2018	£0	0.00%
2019	£0	0.00%
2020	£0	0.00%
2021	£0.740	0.80%
2022	£0	0.00%
2023	£0	0.00%
2024	£0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SGE.L	Dividend Knight	2023-06-01	Semi-Annually	32	1.64%
IEML.L	No Dividend Player	2023-08-10	Insufficient data to determine frequency	2	1.30%
BME.L	Dividend King	2023-06-29	Semi-Annually	11	4.74%
XPP.L	Dividend Knight	2023-09-07	Quarterly	18	1.72%
NWOR.L	Dividend Knight	2023-06-01	Insufficient data to determine frequency	2	0.88%
ENT.L	Dividend Junior	2023-08-17	Annually	19	0.58%
SRE.L	Dividend Knight	2023-07-13	Semi-Annually	18	2.26%
JGGI.L	Dividend King	2023-08-31	Quarterly	53	2.32%
BYIT.L	Dividend Knight	2023-07-20	Annually	4	0.95%
PRSR.L	Dividend Knight	2023-08-10	Quarterly	7	2.62%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.00157	1.500	-0.0314	-0.0471	[0 - 0.5]
returnOnAssetsTTM	-0.00111	1.200	-0.0368	-0.0442	[0 - 0.3]
returnOnEquityTTM	-0.00163	1.500	-1.129	-1.694	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.34	0.800	3.31	2.65	[1 - 3]
quickRatioTTM	1.381	0.800	6.58	5.26	[0.8 - 2.5]
cashRatioTTM	0.686	1.500	7.30	10.00	[0.2 - 2]
debtRatioTTM	0.0520	-1.500	9.13	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.0115	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.00597	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.0755	-1.500	9.70	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.325	1.000	7.92	7.92	[0.2 - 0.8]
operatingProfitMarginTTM	0.00574	1.000	-1.885	-1.885	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.551	1.000	8.05	8.05	[0.2 - 2]
assetTurnoverTTM	0.703	0.800	8.64	6.92	[0.5 - 2]
Total Score				7.50

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-537.02	1.000	-10.00	0	[1 - 100]
returnOnEquityTTM	-0.00163	2.50	-0.726	-1.694	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.00597	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0115	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-1 986.45	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0408	1.000	-1.481	0	[0.1 - 0.5]
Total Score				-0.330

Batm Advanced

BATM Advanced Communications Ltd., together with its subsidiaries, provides real-time technologies for networking solutions and bio-medical systems in Israel, the United States, and Europe. It operates in Networking and Cyber, and Bio-Medical divisions. The Networking and Cyber division is involved in the research and development, production, and marketing of data communication products, including network function virtualization, carrier ethernet and MPLS access solutions, and cyber network monitoring. It also offers software services, such as training and technical support, laboratory service and maintenance; and construction contracts. The Bio-Medical division engages in the research and development, production, marketing, and distribution of medical products, such as laboratory diagnostics and sterilization equipment. This division offers molecular biology diagnostics; provides solutions to treat pathogenic and medical waste in laboratories and hospitals, as well as for pharmaceutical manufacturing plants and agricultural applications; and distributes diagnostic equipment and medical supplies of various brands. BATM Advanced Communications Ltd. has a collaboration with Novamed Ltd for the joint development and marketing of a home-use testing kit for COVID-19. The company was founded in 1992 and is headquartered in Hod Hasharon, Israel.